Introduction
============

Bronchopulmonary dysplasia (BPD), first described in 1967 in premature infants with respiratory distress syndrome ([@r39]), is associated with fewer and enlarged alveoli, suppressed angiogenesis, lack of or insufficient production of surfactant proteins (SPs), and lung inflammation; however, impaired alveolar development and SP deficiency remains the main pathophysiological manifestation of BPD ([@r5]). BDP is the second leading cause of mortality among the infants born before 28 weeks of gestation ([@r12]).

Exposure to a wide range of chemicals and environmental toxicants during pre- and perinatal life may affect the maturation and function of the respiratory system ([@r42]). The risk of cigarette smoke (CS)--associated pulmonary complications is highest during fetal and early postnatal life ([@r17]), yet nearly one-third of prospective mothers smoke during some stages of pregnancy ([@r20]). Epidemiological evidence and animal experiments suggest that parental, particularly maternal, smoking or nicotine exposure adversely affects the pulmonary health of the offspring, including a higher risk for developing allergic asthma, and airway remodeling affecting function ([@r45]; [@r48]; [@r50]; [@r54]). However, it remains unclear whether gestational and/or early postnatal exposure causes BPD. This is an important question because infants with BPD are at increased risk of developing chronic obstructive pulmonary disease (COPD) later in life ([@r4]; [@r10]; [@r36]). In the present study, we show that gestational but not early postnatal exposure of mice to secondhand cigarette smoke (SS) suppresses alveolarization, angiogenesis, and development of Clara and goblet cells without significant lung inflammation and that the SS-induced effects on alveolar architecture are irreversible. Importantly, simultaneous exposure to the nicotinic acetylcholine receptor (nAChR) antagonist mecamylamine (MM) blocks the effects of gestational SS on lung function and alveolar architecture.

Materials and Methods
=====================

*Animals*. Pathogen-free BALB/c or C57BL/6 mice (Frederick National Laboratory for Cancer Research at Fort Detrick, Frederick, MD, USA) were housed in shoebox-type plastic cages with hardwood chip bedding and conditioned to whole-body exposure in exposure chambers for 2 weeks before exposure to SS. The chamber temperature was maintained at 26 ± 2°C, and lights were set to a 12-hr on/off cycle. Food and water were provided *ad libitum*. All animal protocols were approved by the Institutional Animal Care and Use Committee of the Lovelace Respiratory Research Institute. Experimental animals were treated humanely and with regard for alleviation of suffering.

*CS generation and exposure*. Briefly, 70-cm^3^ puffs at the rate of 2/min were generated from 2R1 research cigarettes (Tobacco Health Research Institute, Lexington, KY, USA) by a smoking machine (Type 1300; AMESA Electronics, Geneva, Switzerland). The smoke was captured from the lit end of the cigarette with a plastic manifold placed above it. Male and female mice were exposed to whole-body SS or filtered air (FA) for 6 hr/day, 7 days/week (total particulate matter 1.52 ± 0.41 mg/m^3^) as described previously ([@r49]). This exposure is approximately equivalent to the dose of SS that a pregnant woman would receive by sitting in a smoky bar for 3 hr/day. Immediately after the birth of pups, smoke exposure was stopped; however, some gestationally FA-exposed pups also were exposed to SS until 10 weeks after birth (postnatal SS). \[For additional details, see Supplemental Material, p. 3 (http://dx.doi.org/10.1289/ehp.1306611).\]

*MM treatment*. Before SS or FA exposure, some breeder mice were implanted with subcutaneous mini-osmotic pumps (ALZET Osmotic Pumps, Cupertino, CA, USA) (pumping rate, 0.15 µL/hr) containing saline or MM (2.5 mg/mL), generating the FA (control), MM+FA, SS, and MM+SS groups. Animals were sacrificed at 7 days, 10 weeks, or 8 months after birth.

*Bronchoalveolar lavage fluid (BALF) collection*. Established protocols were followed to obtain BALF from 10-week-old FA (control) and SS-exposed mice ([@r50]). The right pulmonary lobe was lavaged twice with 0.8 mL sterile Ca^2+^/Mg^2+^-free phosphate-buffered saline. The vascular endothelial growth factor (VEGF) level in BALF was determined by ELISA (Biosource-Invitrogen, Carlsbad, CA, USA), according to the manufacturer's directions. Right lungs from some animals were frozen instantaneously in liquid nitrogen and stored at --80 °C for Western blot analysis and quantitative polymerase chain reaction (qPCR) for total RNA. \[For additional details, see Supplemental Material, pp. 3--4, 7--8, (http://dx.doi.org/10.1289/ehp.1306611).\]

*Tissue preparation*. After sacrifice, lungs were removed, inflated and formalin-fixed at a constant hydrostatic pressure ([@r18]). Immediately after inflation, the trachea was ligated and the lungs were immersed in formalin overnight. \[For additional details, see Supplemental Material, p. 4 (http://dx.doi.org/10.1289/ehp.1306611).\]

*Hematoxylin and eosin (H&E) staining*. Standard protocols were followed for H&E staining ([@r49]; [@r55]). The slides were examined with a Nikon Eclipse E600W microscope (Nikon, Tokyo, Japan) with a digital camera.

*Morphometry*. The mean linear intercept (L~m~) was determined on H&E-stained tissue sections using a Nanozoomer Digital Pathology (NDP) slide scanner (Hamamatsu K.K. Photonics, Hamamatsu City, Japan). L~m~ was obtained by dividing the NDP-generated total length of a line drawn across the lung section (scan resolution 20×) by the total number of intercepts encountered per lung section as described previously ([@r25]; [@r52]). The slides were scored for crested alveolar septa using the NDP system with Visiopharm software (Hamamatsu K.K. Photonics) in five randomly computer-selected areas of each lung slide (16,000 µm of alveolar area) of 7-day-, 10-week-, and 8-month-old mice.

*Immunohistochemical (IHC) and immunofluorescence staining*. Lung sections (5 µm) were deparaffinized and hydrated, followed by antigen retrieval ([@r53]). IHC and immunofluorescence were performed to visualize and quantitate the following marker-positive cells:

1.  Surfactant protein-B--positive (SP-B^+^) (1:1,000 dilution; rabbit proSP-B antibody, catalog no. AB3430; Chemicon International, Temecula, CA, USA)

2.  Clara cell secretory protein--positive (CCSP^+^) (Clara cells marker, 1:50,000 dilution; catalog no. 957; Vector)

3.  β-Tubulin^+^ (ciliated cells marker, rabbit anti-β-tubulin antibody from Abcam (Cambridge, UK) followed by Alexa Fluor® 594 fluorescent dye 594--conjugated anti-rabbit antibody)

4.  SPDEF^+^ \[goblet cells marker, guinea pig anti-mouse SPDEF antibody (gift from J. Whitsett, Cincinnati Children's Hospital, Cincinnati, OH, USA)\]

5.  CD34^+^ \[a hematopoietic progenitor cell marker; anti-mouse CD34 antibody, 1:2,000 dilution, (catalog no. 119301; BioLegend, San Diego, CA, USA) followed by Alexa 555--conjugated anti-rat antibody\] and/or CD31^+^ \[an endothelial cell marker; rabbit anti-CD31, 1:2,000 dilution (catalog no. AB28364; Abcam) followed by DyLight 549--conjugated anti-rabbit antibody).

Proximal and distal lung airways images were acquired using CCSP- and SP-B--stained lung sections (Nikon Eclipse E600W microscope) to access SS-effect throughout the lung \[for additional details, see Supplemental Material, pp. 4--8 (http://dx.doi.org/10.1289/ehp.1306611)\].

Trichrome staining. Lung sections were stained with Masson's Trichrome (Sigma-Aldrich, St. Louis, MO, USA) to reveal collagen following standard protocol \[for additional details, see Supplemental Material, p. 7 (http://dx.doi.org/10.1289/ehp.1306611)\].

*Quantitation of IHC-stained SP-B^+^, CCSP^+^, and ciliated epithelial cells*. The slides were scored for SP-B^+^ and CCSP^+^ cells blind using the IHC image analysis software system, NDP.Analyze (Hamamatsu K.K. Photonics) with Visiopharm software (Hoersholm, Denmark). After random selection by computer, four areas of the each lung slide were quantified using 9,000 µm of airways basal lamina. A similar approach was used for the quantitation of surface cilia stained with anti--β-tubulin antibody.

*Western blot analysis*. CD34 were quantitated by Western blotting of the lung homogenates as described previously ([@r49]). The blots were probed with anti-CD34 antibody. Antibody-bound proteins on the blot were detected using enhanced chemiluminescence on X-ray film. \[For additional details, see Supplemental Material, pp. 7--8 (http://dx.doi.org/10.1289/ehp.1306611).\]

*RNA isolation and qPCR*. Lung RNA was isolated as described previously ([@r50]). The lung expression of SP-B, SP-C, SP-A, CCSP, VEGF receptor 2 (VEGFR2), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were determined by qPCR using the One-Step Real-Time PCR MasterMix containing TaqMan probes and a specific-labeled primer/probe set (Applied Biosystems).

*Data presentation and statistical analysis*. Data were analyzed using GraphPad Prism software, version 5.03 (Graphpad Software Inc., San Diego, CA, USA). We used one-way analysis of variation (ANOVA) to compare the mean between the groups, followed by the Tukey post hoc test to compare all groups at 95% confidence intervals (CIs). Student's *t* test was used for comparison between two groups. Results are expressed as the mean ± SD. A *p*-value of ≤ 0.05 was considered statistically significant.

Results
=======

*Prenatal SS exposure suppresses alveolarization*. To determine the effect of prenatal SS exposure on BPD, lung sections from mice exposed gestationally to FA (control) or SS were examined microscopically at 7 days, 10 weeks, and 8 months after birth. H&E staining of lung sections suggested that gestational exposure to SS caused areas of hypoalveolarization in the lung that were seen in the early lung (7 days) as well as at 10 weeks and 8 months after the birth ([Figure 1A,D,G](#f1){ref-type="fig"}, respectively). Changes in lung septation were quantitated by determining the L~m~ of alveoli. Compared to FA animals, the lungs from gestationally SS-exposed animals showed similar increases in L~m~ values (approximately 25%) at 7 days, 10 weeks, and 8 months after birth ([Figure 1B,E,H](#f1){ref-type="fig"}, respectively). Moreover, histopathology of the alveolar septae showed that instead of the elongated secondary septa seen in control lungs, SS-exposed lungs had an increased presence of crested secondary septae, indicating incomplete formation of secondary alveolar septa ([Figure 1A,D,G](#f1){ref-type="fig"})---a feature also seen in human BPD ([@r2]). In lung sections, these crested structures were counted and fold changes over FA-exposed animals were plotted, showing significant increases in secondary crested structures in gestationally SS-exposed animals at 7 days, 10 weeks, and 8 months after birth ([Figure 1C,F,I](#f1){ref-type="fig"}, respectively). On the other hand, postnatal exposure to SS \[postnatal day (PD) 1 through 10 weeks\] did not cause a significant change in alveolarization, and L~m~ values were comparable to those of control animals \[see Supplemental Material, Figure S1A (http://dx.doi.org/10.1289/ehp.1306611)\]. These results indicate that *in utero* but not early postnatal SS exposure impairs alveolar septation, leading to irreversible hypoalveolarization. To ascertain whether BALB/c mice were uniquely susceptible to gestational SS, we also exposed C57BL/6 mice to gestational SS. Results from SS-exposed PD7 lungs from C57BL/6 mice (see Supplemental Material, Figure S1B) showed morphometric changes similar to those observed in BALB/c mice, thus indicating that both BALB/c and C57BL/6 mice develop impaired alveolarization in response to gestational SS.

![Gestational SS exposure affects normal alveolar development in mouse lung. Mice were gestationally exposed to FA or SS and evaluated at 7 days (*A--C*), 10 weeks (*D--F*), or 8 months (*G--I*) of age. Representative lung sections at 20× magnification (*A,D,G*), L~m~ (*B,E,H*), and fold change of crested alveolar septa (*C,F,I*) of lungs from mice. In *A*, *D*, and *G*, arrows indicate crested secondary septae. Data are presented as mean ± SD (*n* = 5). *p* ≤ 0.05 is statistically significant.](ehp.1306611.g001){#f1}

In addition to impaired postnatal lung growth, BPD may cause variable interstitial fibrosis ([@r24]); however, collagen structure (identified by trichrome staining) did not show any significant difference between FA- and SS-exposed 10-week-old lungs \[see Supplemental Material, Figure S2 (http://dx.doi.org/10.1289/ehp.1306611)\]. Moreover, there was no indication of leukocytic infiltration in gestationally SS-exposed lungs (not shown). These results suggest that the SS-induced hypoalveolarization is not associated with significant lung fibrosis or inflammation.

*Gestational SS exposure impairs the development of Clara and goblet cells but not ciliated epithelium cells*. Down-regulation of secretory proteins contributes to the pathology of several airway diseases, including BPD, and many premature infants are given a mixture of surfactant proteins to improve lung function ([@r24]; [@r32]). To determine whether gestational SS broadly affected the airway secretory functions, we examined airway Clara and goblet cells in FA- and SS-exposed mouse lung sections at PD7 by staining for CCSP and SP-B (Clara cell markers) and SPDEF (goblet cell marker). As seen in [Figure 2A](#f2){ref-type="fig"} (CCSP), [Figure 2B](#f2){ref-type="fig"} (SP-B), and [Figure 2C](#f2){ref-type="fig"} (SPDEF), the presence of Clara and goblet cells were significantly reduced in the SS-exposed lung. However, ciliated (β-tubulin^+^) cells ([Figure 2D](#f2){ref-type="fig"}) were not significantly changed by SS exposure in PD7 lung. qPCR analysis ([Figure 2E](#f2){ref-type="fig"}) also showed decreased mRNA expression of CCSP, SP-B, and SP-C. On the other hand, the mRNA expression of SP-A and the number of β-tubulin+ cells per micrometer of basal lamina ([Figure 2E](#f2){ref-type="fig"}) did not show any significant changes between gestationally FA- and SS-exposed lungs. These results indicate that prenatal exposure to SS impairs the development of Clara and goblet cells, which contributes to the reduced production of surfactant proteins and airway mucus in gestationally SS-exposed lungs.

![Gestational SS exposure impairs the development of Clara and goblet cells but not ciliated cells in mouse lung. Mice were gestationally exposed to FA or SS and evaluated at 7 days of age. Lung sections (40× magnification) stained with (*A*) anti-CCSP antibody, (*B*) anti--SP-B antibody, (*C*) anti-SPDEF antibody, and (*D*) anti-β-tubulin antibody for ciliated cells (immunofluorescence image). (*E*) qPCR analysis for CCSP, SP-B, SP-C, SP-A, and surface cilia per micrometer of basal lamia. NS, not significant. Arrows show stained cells in the airways. Data are presented as mean ± SD (n = 3--5). \**p* ≤ 0.05. \*\**p* ≤ 0.01.](ehp.1306611.g002){#f2}

To determine whether gestational SS affected the airway secretory cells uniformly, the distribution of CCSP and SP-B in the airways was assessed by IHC staining in the proximal and distal airways. Results indicated that both proximal and distal airways were affected similarly by gestational SS \[see Supplemental Material, Figures S3 and S4 (http://dx.doi.org/10.1289/ehp.1306611)\].

*Gestational SS impairs airway angiogenesis*. Angiogenesis is a tightly regulated physiological process that occurs during embryogenesis ([@r9]) and plays a vital role in the development of the lung and airways ([@r30]), and new alveolar septa formation is closely associated with microvascular maturation ([@r11]). We evaluated lung vascularization by immunofluorescence by staining for CD34, a transmembrane glycoprotein expressed primarily by endothelial cells and strongly present in alveolar wall capillaries ([@r43]). Tissue sections were also stained for cell nuclei with DAPI. Compared to controls (FA), the SS-exposed lungs at PD7 exhibited much weaker immunofluorescence ([Figure 3A](#f3){ref-type="fig"}) for CD34, indicating a decreased number of endothelial cells in gestationally SS-exposed lungs. Western blots of the lung extracts from FA- and SS-exposed animals also showed that SS-exposed lungs had significantly reduced levels of CD34 immunoreactive protein ([Figure 3B](#f3){ref-type="fig"}). Decreased angiogenesis in SS-exposed lungs was further confirmed by immunofluorescence for CD31 ([Figure 3C](#f3){ref-type="fig"}), a major constituent of endothelial cell intercellular junctions ([@r35]) that is absent on nonvascular cells such as epithelium, fibroblasts, and muscle cells ([@r37]). These results indicate that gestational SS exposure strongly suppresses/impairs vascular development in the lung.

![Gestational SS exposure inhibits angiogenesis. Mice were gestationally exposed to FA or SS. (*A*) Immunofluorescence images (400× magnification) of representative lung sections from 7-day-old mice stained with anti-CD34/anti-rat conjugated Alexa 555. Nuclei are indicated by blue fluorescence and CD34 by red fluorescence. (*B*) Western blot of protein from 70 μg lung homogenate from 7‑day-old mice. (*C*) Representative immunofluorescence image of lung from 7‑day-old mice stained with anti-CD31 (PECAM‑1). (*D*) VEGFR2 in lung from 7‑day-old mice determined by qPCR. (*E*) VEGF level in BALF in lung from 10-week-old mice determined by ELISA. Data are presented as mean ± SD (*n* = 5). \**p* ≤ 0.05. \*\**p* ≤ 0.01.](ehp.1306611.g003){#f3}

Coordinated and timely release of angiogenic growth factors from respiratory epithelial cells promotes normal alveolar development ([@r51]). Although multiple factors affect angiogenesis, VEGF plays an important role in postnatal lung alveolar development as well as in the maintenance of alveolar structures in the adult lung ([@r13]; [@r23]; [@r38]; [@r46]; [@r56]). The expression of VEGFRs increases during lung development, and most of the VEGF effects are mediated through VEGFR2 ([@r22]; [@r38]). We determined the expression of VEGFR2 by qPCR in the PD7 lung from FA- and SS-exposed mice. VEGFR2 expression was significantly reduced in the SS-exposed animals ([Figure 3D](#f3){ref-type="fig"}). Moreover, the concentration of VEGF in BALF from SS-exposed mouse lungs at 10 weeks after birth was significantly lower than in BALF from control lungs ([Figure 3E](#f3){ref-type="fig"}). These results suggest that gestational exposure to SS causes angiogenic defects in the developing lung, and the decreased expression of VEGF and its main receptor VEGFR2 are likely to contribute to the defective angiogenesis of the lung in gestationally SS-exposed animals.

*MM blocks SS-induced effects on lung pathology.* Nicotine is the major component of SS. Therefore, it was possible that the SS-induced BPD-like condition was regulated by nAChRs, and blocking these receptors would prevent the gestational SS-induced injury to the lung. We observed that while MM (an nAChR antagonist) treatment during gestational period alone did not significantly affect alveolarization and L~m~ of PD7 lung, it blocked the effects of gestational SS on alveolar septation ([Figure 4A](#f4){ref-type="fig"}) and L~m~ values ([Figure 4B](#f4){ref-type="fig"}). Furthermore, immunofluorescence staining for CD31 ([Figure 4C](#f4){ref-type="fig"}) of the lung section and qPCR analysis for VEGFR2 ([Figure 4D](#f4){ref-type="fig"}) indicated that pretreatment with MM also normalized lung vascularization (CD31 expression) and the VEGFR2 level in the PD7 lung. Similarly, qPCR analysis indicated that MM restored the levels of SP-B ([Figure 5A](#f5){ref-type="fig"}) and CCSP ([Figure 5B](#f5){ref-type="fig"}) and also suppressed the SS-induced reduction in the airway SP-B staining ([Figure 5C](#f5){ref-type="fig"}) and CCSP staining ([Figure 5D](#f5){ref-type="fig"}). MM countered the effects of SS on SP-B^+^ cells ([Figure 5E](#f5){ref-type="fig"}) and CCSP^+^ cells ([Figure 5F](#f5){ref-type="fig"}). Moreover, MM restored CCSP^+^ and SP-B^+^ cells throughout the airways \[see Supplemental Material, Figures S3 and S4 (http://dx.doi.org/10.1289/ehp.1306611)\]. Thus, MM treatment essentially blocks the inhibitory effects of gestational SS on alveolarization, vascularization, and secretory/surfactant protein production, indicating a critical role of nAChRs in the development of SS-induced BPD.

![Gestational SS-induced effects on alveolarization and angeiogenesis are blocked by MM. Mice were gestationally exposed to FA or SS with or without MM exposure and evaluated at 7 days of age. (*A*) Representative lung sections (40× magnification: stained with H&E). (*B*) Percent L~m~. (*C*) Representative immunofluorescence images of lung sections stained with anti-CD31 (PECAM-1)/anti-rabbit DyLight 549. (*D*) qPCR analysis of VEGFR2. Data are presented as mean ± SD (*n* = 5). \**p* ≤ 0.05, compared with FA. \*\**p* ≤ 0.01, and ^†^*p* ≤ 0.001, compared with SS.](ehp.1306611.g004){#f4}

![Gestational SS-induced effect on Clara cells is blocked by MM. Mice were gestationally exposed to FA or SS with or without MM exposure and evaluated at 7 days of age. qPCR analysis of SP-B (*A*) and CCSP (*B*) in lung. Representative IHC image (40× magnification) of lung stained for SP-B (*C*) and CCSP (*D*); arrows indicate positive cells in the lung airways. SP-B^+^ (*E*) and CCSP^+^ (*F*) cells per micrometer of basal lamina. Data are presented as mean ± SD (*n* = 5). \**p* ≤ 0.05. \*\**p* ≤ 0.01. ^†^*p* ≤ 0.001.](ehp.1306611.g005){#f5}

Discussion
==========

Increasing evidence suggests that *in utero* exposure to environmental toxins, including polycyclic aromatic hydrocarbons and CS/nicotine affect lung development and function ([@r41]; [@r45]; [@r48]; [@r49]; [@r54]). In addition, in rats maternal exposure to nicotine during gestation and lactation produced oxidative stress--related lung impairment, including microscopic emphysema during adult life ([@r29]). In humans, intrauterine exposure to CS has been deemed a risk factor for BPD ([@r6]); however, to our knowledge, this has remained unconfirmed. BPD is a disease whose etiology has not been fully established. Here we present evidence that gestational, but not early postnatal exposure of BALB/c and C57BL/6 mice to SS causes BPD and the PD7 lung exhibit hypoalveolarization and significant increases in L~m~ (≥⊇23%) comparable to some patients with COPD/emphysema ([@r21]).

Chronic exposure to CS is the most important cause of COPD/emphysema in humans, and the loss of alveolar surface is associated with increased concentrations of metalloproteinases (MMP) ([@r34]). MMP-12 is implicated in CS-induced emphysema ([@r8]); however, MMP-12 was not elevated in SS-exposed mice (not shown), suggesting that, although classical emphysema is progressive and results from dissolution of preformed alveolar septae, the SS-induced BPD results from impaired formation of secondary alveolar septae and, in the absence of additional lung insults, is not progressive. This inference is further supported by the histopathology of SS-exposed PD7 lung showing the increased presence of crested secondary septa (i.e., incomplete formation of secondary alveolar septa). These results suggest that gestational SS-induced BPD results primarily from impaired alveolar maturation ([@r3]).

Interaction between epithelial and vascular compartments is critical in alveologenesis, and coordinated and timely release of angiogenic growth factors from respiratory epithelial cells promotes normal alveolar development ([@r51]). The development of fewer alveoli and microvessels is a quintessential feature of neonatal chronic lung disease ([@r16]) and pulmonary endothelium is closely apposed to the developing epithelium ([@r38]). VEGF is the most potent mediator of angiogenesis ([@r13]; [@r38]), and it plays a significant role in the pathophysiology of common respiratory disorders, including acute lung injury, asthma, COPD, pulmonary fibrosis, and lung cancer ([@r40]). The angiogenic effects of VEGF are primarily mediated through VEGFR2 ([@r22]; [@r38]). Consistent with the critical role of VEGF and VEGFR2 in BPD, human infants who die of BPD have little or no VEGF in their lung epithelium. BPD is also associated with decreased levels of angiogenic progenitor cells in cord blood ([@r7]) and reduction of VEGFRs in pulmonary vasculature ([@r51]). CD34 is present on endothelial cells, and is involved in leukocyte adhesion and endothelial cell migration during angiogenesis ([@r43]). The expression of CD34 in the PD7 SS-exposed lung was severely reduced. Because CD34 is also present on progenitor hematopoietic cells ([@r14]), to ensure that SS affected the vascular endothelial cells, we also determined the expression of CD31---a major constituent of the endothelial cell intercellular junction ([@r35]). As with CD34, the lung expression of CD31 was much lower in gestationally SS-exposed animals than FA controls. Similarly, the lung expression of other parameters of angiogenesis, such as VEGF and VEGFR2 were significantly decreased in the 10-week SS-exposed lungs. Similarly, in preterm children with BPD, VEGF levels remain significantly lower than preterm children without BPD ([@r31]). Decreased expression of VEGFR2 was also seen by microarray analysis of carotid arteries in monkeys exposed during gestation and early postnatal life to environmental tobacco smoke ([@r31]). Together, these results suggest that decreased alveolarization in gestationally SS-exposed lung may reflect the reduction in angiogenesis that affects lung vascularization.

Another characteristic of BPD is the decreased production of CCSP and SP-B ([@r31]). CCSP modulates immune responses, reduces lung injury in animal models, up-regulates the expression of surfactant proteins and VEGF in the lung, and ameliorates BPD ([@r44]). SP-B lowers surface tension and prevents atelectasis and protects epithelial cells ([@r1]), and its administration may improve lung functions in BPD ([@r27]; [@r32]). The expression of CCSP, SP-B, and SP-C is significantly down-regulated in the gestationally SS-exposed PD7 lungs. However, the expression of SP-A surfactant protein was comparable in gestationally FA- and SS-exposed animals. This disparity between the expression of SP-A and other surfactant proteins in SS-induced BPD is not clear; however, in the lung SP-A is also made by airway submucosal gland cells ([@r47].)

There are three major epithelial cell types in the airways: ciliated cells, Clara cells, and goblet cells. Ciliated epithelium participates in the mucociliary clearance and expresses β-tubulin on the surface ([@r53]), whereas Clara cells and goblet cells express CCSP and SPDEF, respectively. IHC analysis clearly indicated that gestational SS did not significantly affect ciliated (β-tubulin^+^) cells, but a drastic reduction was noted in CCSP^+^ and SPDEF^+^ cells in the airways.

Thus, the severe lack of secretory proteins in SS-exposed lungs may reflect impaired or delayed development of these cells in the SS-exposed lung. Indeed, impaired airway secretory function such as mucus formation ([@r49]) and CCSP/SP-B was evident even at 10 weeks after the birth of gestationally SS-exposed animals \[see Supplemental Material, Figure S5A,B (http://dx.doi.org/10.1289/ehp.1306611)\]. Decreased presence of CCSP^+^ cells was observed both in proximal and distal areas of the airways, suggesting the effects of gestational SS on maturation and differentiation of type II epithelial cells. Additionally, CCSP stimulates VEGF and alveologenesis ([@r1]; [@r28]), and the decreased expression of VEGF may contribute to impaired angiogenesis and alveologenesis in SS-exposed lungs.

SS contains many toxic chemicals, including nicotine, and nAChRs are present on many non-neuronal cell types, including endothelial ([@r15]) and lung epithelial cells ([@r19]). Thus, it is possible that SS affects lung alveolarization, angiogenesis, and surfactant proteins through nAChRs. Moreover, in rats nicotine treatment during gestation was shown to affect some aspects of lung development ([@r29]). Treatment with the nAChR antagonist MM during the gestational period ameliorated the effects of gestational SS on alveolarization, angiogenesis, and airway secretory function. These results suggest that nAChRs are critical in SS-induced BPD. A surprising observation was that the *in utero* SS effects on some lung parameters were opposite of those observed in adult mice after CS/nicotine exposure. For example, exposure of adult mice to CS/nicotine suppresses allergic responses ([@r33]), but prenatal exposure to SS strongly exacerbates allergen-induced atopy and T-helper 2 (Th2) cell polarization ([@r49]). Similarly, unlike its anti-angiogenic effects during gestational period, nicotine stimulates neovascularization ([@r15]) and airways mucus formation ([@r19]; [@r49]). A potential explanation is that long-term exposure to low levels of CS/nicotine may promote desensitization or loss of nAChRs, and these receptors may be important in regulating lung growth. Although currently we have no direct evidence to support this possibility, recent papers suggest that whereas short-term exposure to nicotine may promote angiogenesis and VEGF production, long-term exposures to nicotine may impair cholinergic angiogenesis and impair capillary sprouting ([@r26]).

Although maternal smoking has been considered a risk factor for BPD in children ([@r6]), mice might be particularly sensitive to pro-BPD effects of SS. Alternatively, unlike humans, experimental mice are inbred and the presence of susceptibility factors on both alleles might make them more susceptible to CS-induced BPD. Nonetheless, this excessive susceptibility might make an excellent model to study the mechanism of BPD. Interestingly, postnatal SS had very little effect on the development of BPD. In view of recent human data suggesting that exposure to CS during the first trimester is sufficient to increase the risk of asthma in children ([@r54]), CS-induced changes during early embryogenesis might be critical for BPD. Overall, the present study shows that exposure to environmental tobacco smoke during gestation interferes with alveolarization and promotes a BPD-like syndrome. These effects of SS are mediated through nAChRs, and antagonists of nAChRs may have therapeutic value in blocking the effects of CS/nicotine on fetal lung development.
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=====================
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